Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.26 -0.18 (-0.86%)
As of: Oct 21, 2026 · 1:40 PM EDT

Acadia Pharmaceuticals (ACAD) Revenue (2010 - 2026)

Updated

Acadia Pharmaceuticals' Revenue came in at $307.96 million for Q2 2026, up 16.4% from $264.57 million a year earlier and up 14.9% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Revenue (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Acadia Pharmaceuticals reported Revenue of $1.14 billion, up 11.8% year-over-year; for FY2025, it came in at $1.07 billion, up 11.9% from FY2024.

  • Revenue has increased in each of the last nine years, with a five-year compound annual growth rate of 19.4% (FY2020 to FY2025).
  • Going back by year, Revenue was $957.8 million in FY2024 (+31.8%), $726.44 million in FY2023 (+40.4%), $517.24 million in FY2022 (+6.8%) and $484.15 million in FY2021 (+9.6%).
  • The Q2 2026 figure represents the highest quarterly Revenue in data going back to Q2 2010.
  • Year-over-year, Revenue has increased for 15 consecutive quarters, with growth averaging 13.2% over the last eight quarters.
  • The fastest year-over-year change in Revenue over five years came in Q1 2024 (growth of 73.8%), and the weakest in Q3 2022 (a decline of 0.7%).
  • Business Quant data shows ACAD's Revenue at $268.06 million (Q1 2026), $283.99 million (Q4 2025) and $278.63 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Acadia Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ACAD&period=max&api_key=YOUR_API_KEY